Professor Mark Morrison
Professor

Mark Morrison

Email: 
Phone: 
+61 7 344 36957

Availability

Professor Mark Morrison is:
Available for supervision

Fields of research

Biomedical and Clinical Sciences Clinical microbiology Clinical sciences Gastroenterology and hepatology Medical biochemistry and metabolomics Medical microbiology

Qualifications

  • Bachelor of Science, University of New South Wales
  • Masters (Research) of Science, James Cook University
  • Doctor of Philosophy, University of Illinois

Search Professor Mark Morrison’s works on UQ eSpace

425 works between 1990 and 2026
All (425) Journal Article (262) Conference Publication (155) Book Chapter (8)

1 - 20 of 425 works

2026

Journal Article

Genomic, proteolytic, and phenotypic characterization of <i>Pseudomonas aeruginosa</i> isolates causing infective endocarditis

Hickson, Sarah M., Torres, Von Vergel L., Teh, Jing Jie, O’Keefe, Ian, Ernst, Robert K., Morrison, Mark, McCarthy, Kate L. and Wells, Timothy J. (2026). Genomic, proteolytic, and phenotypic characterization of Pseudomonas aeruginosa isolates causing infective endocarditis. Microbiology Spectrum e03742-25. doi: 10.1128/spectrum.03742-25

Genomic, proteolytic, and phenotypic characterization of <i>Pseudomonas aeruginosa</i> isolates causing infective endocarditis

2026

Journal Article

Su1485 THE RESISTOME OF THE COLONIC MUCOSA-ASSOCIATED MICROBIOTA VARIES IN FORM AND FUNCTION BETWEEN THE EAST AND WEST, AND IN CROHN’S DISEASE AND HEALTH. THE ENIGMA STUDY

Kang, Seungha, Teh, Jingjie, Zhang, Jingwan, Zheng, Jiaying, Sun, Qianru, Yang, Wanyi, Hamilton, Amy L., Wilson-O’Brien, Amy, Trakman, Gina L., Ching, Jessica Y., Sung, Joseph JY, Ng, Siew C., Kamm, Michael A. and Morrison, Mark (2026). Su1485 THE RESISTOME OF THE COLONIC MUCOSA-ASSOCIATED MICROBIOTA VARIES IN FORM AND FUNCTION BETWEEN THE EAST AND WEST, AND IN CROHN’S DISEASE AND HEALTH. THE ENIGMA STUDY. Gastrointestinal Endoscopy, 103 (5), S-1041. doi: 10.1016/s0016-5107(26)02623-4

Su1485 THE RESISTOME OF THE COLONIC MUCOSA-ASSOCIATED MICROBIOTA VARIES IN FORM AND FUNCTION BETWEEN THE EAST AND WEST, AND IN CROHN’S DISEASE AND HEALTH. THE ENIGMA STUDY

2026

Journal Article

729 FAECAL MICROBIOTA TRANSPLANTATION FOR ACTIVE CROHN’S DISEASE: THE MIRO (MICROBIAL RESTORATION) RANDOMISED PLACEBO-CONTROLLED TRIAL

Fehily, Sasha R., Wright, Emily K., Bogatic, Damjana, O’ Brien, Amy Wilson, Basnayake, Chamara, Stanley, Annalise, Marks, Elise, Russell, Erin, Yuwei, Rong, Gory, Ilana, Ardalan, Zaid, Hamilton, Amy L., Morrison, Mark, Thompson, Alexander, Bryant, Robert V., Costello, Samuel and Kamm, Michael A. (2026). 729 FAECAL MICROBIOTA TRANSPLANTATION FOR ACTIVE CROHN’S DISEASE: THE MIRO (MICROBIAL RESTORATION) RANDOMISED PLACEBO-CONTROLLED TRIAL. Gastrointestinal Endoscopy, 103 (5), S-895. doi: 10.1016/s0016-5107(26)02303-5

729 FAECAL MICROBIOTA TRANSPLANTATION FOR ACTIVE CROHN’S DISEASE: THE MIRO (MICROBIAL RESTORATION) RANDOMISED PLACEBO-CONTROLLED TRIAL

2026

Journal Article

Mo1618 EMULSIFIER POLYSORBATE 80 EXHIBITS DISTINCT DEGRADATION IN CROHN’S DISEASE MEDIATED BY ALTERED GUT MICROBIOME. THE ENIGMA STUDY

Zhang, Jingwan, Tang, Xinyi, Hao, Fangjia, Kang, Seungha, Teh, Jing Jie, Trakman, Gina L., Zheng, Jiaying, SUN, Qianru, Liu, Yingzhi, Hamilton, Amy L., O’ Brien, Amy Wilson, Ching, Jessica Y., Sun, Yang, Zhang, Lin, Miao, Yinglei, Chan, Francis K., Sung, Joseph JY, Morrison, Mark, Kamm, Michael A. and Ng, Siew C. (2026). Mo1618 EMULSIFIER POLYSORBATE 80 EXHIBITS DISTINCT DEGRADATION IN CROHN’S DISEASE MEDIATED BY ALTERED GUT MICROBIOME. THE ENIGMA STUDY. Gastroenterology, 170 (6), S-1213. doi: 10.1016/s0016-5085(26)03057-x

Mo1618 EMULSIFIER POLYSORBATE 80 EXHIBITS DISTINCT DEGRADATION IN CROHN’S DISEASE MEDIATED BY ALTERED GUT MICROBIOME. THE ENIGMA STUDY

2026

Journal Article

729 FAECAL MICROBIOTA TRANSPLANTATION FOR ACTIVE CROHN’S DISEASE: THE MIRO (MICROBIAL RESTORATION) RANDOMISED PLACEBO-CONTROLLED TRIAL

Fehily, Sasha R., Wright, Emily K., Bogatic, Damjana, O’ Brien, Amy Wilson, Basnayake, Chamara, Stanley, Annalise, Marks, Elise, Russell, Erin, Yuwei, Rong, Gory, Ilana, Ardalan, Zaid, Hamilton, Amy L., Morrison, Mark, Thompson, Alexander, Bryant, Robert V., Costello, Samuel and Kamm, Michael A. (2026). 729 FAECAL MICROBIOTA TRANSPLANTATION FOR ACTIVE CROHN’S DISEASE: THE MIRO (MICROBIAL RESTORATION) RANDOMISED PLACEBO-CONTROLLED TRIAL. Gastroenterology, 170 (6), S-895. doi: 10.1016/s0016-5085(26)02372-3

729 FAECAL MICROBIOTA TRANSPLANTATION FOR ACTIVE CROHN’S DISEASE: THE MIRO (MICROBIAL RESTORATION) RANDOMISED PLACEBO-CONTROLLED TRIAL

2026

Journal Article

Sa1435 PLATELET-ACTIVATING FACTOR RECEPTOR PRESENTS PHOSPHORYLCHOLINE TO TOLL-LIKE RECEPTOR 4 DURING COLITIS

Sherwin, Simonne, Schooth, Lauren F., Liu, Gang, Soh, Wai Sinn, Pryor, Jennifer C., Burns, Grace L., Minahan, Kyra, Morrison, Mark and Keely, Simon (2026). Sa1435 PLATELET-ACTIVATING FACTOR RECEPTOR PRESENTS PHOSPHORYLCHOLINE TO TOLL-LIKE RECEPTOR 4 DURING COLITIS. Gastroenterology, 170 (6), S-930. doi: 10.1016/s0016-5085(26)02447-9

Sa1435 PLATELET-ACTIVATING FACTOR RECEPTOR PRESENTS PHOSPHORYLCHOLINE TO TOLL-LIKE RECEPTOR 4 DURING COLITIS

2026

Journal Article

Sa1435 PLATELET-ACTIVATING FACTOR RECEPTOR PRESENTS PHOSPHORYLCHOLINE TO TOLL-LIKE RECEPTOR 4 DURING COLITIS

Sherwin, Simonne, Schooth, Lauren F., Liu, Gang, Soh, Wai Sinn, Pryor, Jennifer C., Burns, Grace L., Minahan, Kyra, Morrison, Mark and Keely, Simon (2026). Sa1435 PLATELET-ACTIVATING FACTOR RECEPTOR PRESENTS PHOSPHORYLCHOLINE TO TOLL-LIKE RECEPTOR 4 DURING COLITIS. Gastrointestinal Endoscopy, 103 (5), S-930. doi: 10.1016/s0016-5107(26)02378-3

Sa1435 PLATELET-ACTIVATING FACTOR RECEPTOR PRESENTS PHOSPHORYLCHOLINE TO TOLL-LIKE RECEPTOR 4 DURING COLITIS

2026

Journal Article

Mo1501 CLOAKING ANTIBODIES: A NEWLY IDENTIFIED CAUSE OF CROHN’S DISEASE INFLAMMATION AND COMPLICATIONS, A PROGNOSTIC MARKER, AND A TREATMENT TARGET

Feng, Wenkang, Tovey-Matthews, Abigail, Wright, Emily K., Hamilton, Amy L., Kang, Seungha, Davies, Julie, Lovett, Grace C., Schulberg, Julien D., Kamm, Michael A., Morrison, Mark and Wells, Timothy (2026). Mo1501 CLOAKING ANTIBODIES: A NEWLY IDENTIFIED CAUSE OF CROHN’S DISEASE INFLAMMATION AND COMPLICATIONS, A PROGNOSTIC MARKER, AND A TREATMENT TARGET. Gastrointestinal Endoscopy, 103 (5), S-1159. doi: 10.1016/s0016-5107(26)02871-3

Mo1501 CLOAKING ANTIBODIES: A NEWLY IDENTIFIED CAUSE OF CROHN’S DISEASE INFLAMMATION AND COMPLICATIONS, A PROGNOSTIC MARKER, AND A TREATMENT TARGET

2026

Journal Article

822 MACHINE LEARNING-DRIVEN INTEGRATED ANALYSIS OF MULTINATIONAL MICROBIAL, DIET AND CLINICAL DATA IDENTIFIES THE DETERMINANTS OF CROHN’S DISEASE. THE ENIGMA STUDY

Yang, Wanyi, Zheng, Jiaying, Sun, Qianru, Kang, Seungha, Teh, Jingjie, Trakman, Gina L., Hamilton, Amy L., O’ Brien, Amy Wilson, Ching, Jessica Y., Sun, Yang, Chan, Francis K., Miao, Yinglei, Sung, Joseph JY, Morrison, Mark, Kamm, Michael A., Ng, Siew C. and Zhang, Jingwan (2026). 822 MACHINE LEARNING-DRIVEN INTEGRATED ANALYSIS OF MULTINATIONAL MICROBIAL, DIET AND CLINICAL DATA IDENTIFIES THE DETERMINANTS OF CROHN’S DISEASE. THE ENIGMA STUDY. Gastrointestinal Endoscopy, 103 (5), S-899. doi: 10.1016/s0016-5107(26)02310-2

822 MACHINE LEARNING-DRIVEN INTEGRATED ANALYSIS OF MULTINATIONAL MICROBIAL, DIET AND CLINICAL DATA IDENTIFIES THE DETERMINANTS OF CROHN’S DISEASE. THE ENIGMA STUDY

2026

Journal Article

Su1485 THE RESISTOME OF THE COLONIC MUCOSA-ASSOCIATED MICROBIOTA VARIES IN FORM AND FUNCTION BETWEEN THE EAST AND WEST, AND IN CROHN’S DISEASE AND HEALTH. THE ENIGMA STUDY

Kang, Seungha, Teh, Jingjie, Zhang, Jingwan, Zheng, Jiaying, Sun, Qianru, Yang, Wanyi, Hamilton, Amy L., Wilson-O’Brien, Amy, Trakman, Gina L., Ching, Jessica Y., Sung, Joseph JY, Ng, Siew C., Kamm, Michael A. and Morrison, Mark (2026). Su1485 THE RESISTOME OF THE COLONIC MUCOSA-ASSOCIATED MICROBIOTA VARIES IN FORM AND FUNCTION BETWEEN THE EAST AND WEST, AND IN CROHN’S DISEASE AND HEALTH. THE ENIGMA STUDY. Gastroenterology, 170 (6), S-1041. doi: 10.1016/s0016-5085(26)02692-2

Su1485 THE RESISTOME OF THE COLONIC MUCOSA-ASSOCIATED MICROBIOTA VARIES IN FORM AND FUNCTION BETWEEN THE EAST AND WEST, AND IN CROHN’S DISEASE AND HEALTH. THE ENIGMA STUDY

2026

Journal Article

822 MACHINE LEARNING-DRIVEN INTEGRATED ANALYSIS OF MULTINATIONAL MICROBIAL, DIET AND CLINICAL DATA IDENTIFIES THE DETERMINANTS OF CROHN’S DISEASE. THE ENIGMA STUDY

Yang, Wanyi, Zheng, Jiaying, Sun, Qianru, Kang, Seungha, Teh, Jingjie, Trakman, Gina L., Hamilton, Amy L., O’ Brien, Amy Wilson, Ching, Jessica Y., Sun, Yang, Chan, Francis K., Miao, Yinglei, Sung, Joseph JY, Morrison, Mark, Kamm, Michael A., Ng, Siew C. and Zhang, Jingwan (2026). 822 MACHINE LEARNING-DRIVEN INTEGRATED ANALYSIS OF MULTINATIONAL MICROBIAL, DIET AND CLINICAL DATA IDENTIFIES THE DETERMINANTS OF CROHN’S DISEASE. THE ENIGMA STUDY. Gastroenterology, 170 (6), S-899. doi: 10.1016/s0016-5085(26)02379-6

822 MACHINE LEARNING-DRIVEN INTEGRATED ANALYSIS OF MULTINATIONAL MICROBIAL, DIET AND CLINICAL DATA IDENTIFIES THE DETERMINANTS OF CROHN’S DISEASE. THE ENIGMA STUDY

2026

Journal Article

Mo1618 EMULSIFIER POLYSORBATE 80 EXHIBITS DISTINCT DEGRADATION IN CROHN’S DISEASE MEDIATED BY ALTERED GUT MICROBIOME. THE ENIGMA STUDY

Zhang, Jingwan, Tang, Xinyi, Hao, Fangjia, Kang, Seungha, Teh, Jing Jie, Trakman, Gina L., Zheng, Jiaying, SUN, Qianru, Liu, Yingzhi, Hamilton, Amy L., O’ Brien, Amy Wilson, Ching, Jessica Y., Sun, Yang, Zhang, Lin, Miao, Yinglei, Chan, Francis K., Sung, Joseph JY, Morrison, Mark, Kamm, Michael A. and Ng, Siew C. (2026). Mo1618 EMULSIFIER POLYSORBATE 80 EXHIBITS DISTINCT DEGRADATION IN CROHN’S DISEASE MEDIATED BY ALTERED GUT MICROBIOME. THE ENIGMA STUDY. Gastrointestinal Endoscopy, 103 (5), S-1213. doi: 10.1016/s0016-5107(26)02988-3

Mo1618 EMULSIFIER POLYSORBATE 80 EXHIBITS DISTINCT DEGRADATION IN CROHN’S DISEASE MEDIATED BY ALTERED GUT MICROBIOME. THE ENIGMA STUDY

2026

Journal Article

Mo1501 CLOAKING ANTIBODIES: A NEWLY IDENTIFIED CAUSE OF CROHN’S DISEASE INFLAMMATION AND COMPLICATIONS, A PROGNOSTIC MARKER, AND A TREATMENT TARGET

Feng, Wenkang, Tovey-Matthews, Abigail, Wright, Emily K., Hamilton, Amy L., Kang, Seungha, Davies, Julie, Lovett, Grace C., Schulberg, Julien D., Kamm, Michael A., Morrison, Mark and Wells, Timothy (2026). Mo1501 CLOAKING ANTIBODIES: A NEWLY IDENTIFIED CAUSE OF CROHN’S DISEASE INFLAMMATION AND COMPLICATIONS, A PROGNOSTIC MARKER, AND A TREATMENT TARGET. Gastroenterology, 170 (6), S-1159. doi: 10.1016/s0016-5085(26)02940-9

Mo1501 CLOAKING ANTIBODIES: A NEWLY IDENTIFIED CAUSE OF CROHN’S DISEASE INFLAMMATION AND COMPLICATIONS, A PROGNOSTIC MARKER, AND A TREATMENT TARGET

2026

Journal Article

Quantifying artificial sweeteners and emulsifiers in Crohn’s disease and its relationship with disease activity: the ENIGMA study – a novel and targeted approach

Zhang, Jingwan, Hu, Jielun, Tang, Xinyi, Ruan, Yanjiao, Hao, Fangjia, Zhang, Wenqing, Trakman, Gina, Hamilton, Amy L, Lin, Winnie, Sun, Yang, Ching, Jessica Y L, Teh, Jing Jie, Kang, Seungha, Wilson-O’ Brien, Amy, Stanley, Annalise, Zhang, Lin, Sung, Joseph J Y, Yu, Jun, Miao, Yinglei, Chan, Francis K L, Morrison, Mark, Kamm, Michael and Ng, Siew C (2026). Quantifying artificial sweeteners and emulsifiers in Crohn’s disease and its relationship with disease activity: the ENIGMA study – a novel and targeted approach. Gut, gutjnl-2024. doi: 10.1136/gutjnl-2024-333999

Quantifying artificial sweeteners and emulsifiers in Crohn’s disease and its relationship with disease activity: the ENIGMA study – a novel and targeted approach

2026

Journal Article

Metagenomic analysis of fecal microbiomes reveals genetic potential for diverse hydrogen management strategies in marsupials

Bowerman, Kate L., Lu, Yang, McRae, Harley, Volmer, James G., Zaugg, Julian, Pope, Phillip B., Hugenholtz, Philip, Greening, Chris, Morrison, Mark, Soo, Rochelle M. and Evans, Paul N. (2026). Metagenomic analysis of fecal microbiomes reveals genetic potential for diverse hydrogen management strategies in marsupials. mSystems, 11 (2) e01608-25, 1-16. doi: 10.1128/msystems.01608-25

Metagenomic analysis of fecal microbiomes reveals genetic potential for diverse hydrogen management strategies in marsupials

2026

Journal Article

A molecular inventory of the faecal microbiomes of 23 marsupial species

Bowerman, Kate L., Soo, Rochelle M., Chaumeil, Pierre-Alain, Blyton, Michaela D. J., Sørensen, Mette, Gunbilig, Disan, Malig, Maika, Islam, Moutusee, Zaugg, Julian, Wood, David L. A., Liachko, Ivan, Auch, Benjamin, Morrison, Mark, Krause, Lutz, Lindberg Møller, Birger, Neilson, Elizabeth H. J. and Hugenholtz, Philip (2026). A molecular inventory of the faecal microbiomes of 23 marsupial species. Microbial Genomics, 12 (1) 001601. doi: 10.1099/mgen.0.001601

A molecular inventory of the faecal microbiomes of 23 marsupial species

2026

Conference Publication

OP15 Faecal microbiota transplantation for active Crohn's disease: the MIRO (Microbial Restoration) randomised placebo-controlled trial

Fehily, S., Wright, E. K., Bogatic, D., Wilson-O'brien, A., Basnayake, C., Stanley, A., Marks, E., Russell, E., Rong, Y., Gory,, Ardalan, Z., Hamilton, A., Morrison, M., Thompson, A., Bryant, R., Costello, S. P. and Kamm, M. A. (2026). OP15 Faecal microbiota transplantation for active Crohn's disease: the MIRO (Microbial Restoration) randomised placebo-controlled trial. 21st Congress of the European Crohn’s and Colitis Organisation (ECCO), Stockholm, Sweden, 18–21 February 2026. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ecco-jcc/jjaf231.015

OP15 Faecal microbiota transplantation for active Crohn's disease: the MIRO (Microbial Restoration) randomised placebo-controlled trial

2026

Journal Article

Effects of dietary FODMAP content on the faecal microbiome and gastrointestinal physiology in healthy adults: a randomised, controlled cross-over feeding study

Murtaza, Nida, Collins, Lyndal, Yao, Chu K., Thwaites, Phoebe A., Veitch, Patricia, Varney, Jane E., Gill, Paul A., Gibson, Peter R., Morrison, Mark and Muir, Jane G. (2026). Effects of dietary FODMAP content on the faecal microbiome and gastrointestinal physiology in healthy adults: a randomised, controlled cross-over feeding study. The British Journal of Nutrition, 134 (9), 712-726. doi: 10.1017/s0007114525000868

Effects of dietary FODMAP content on the faecal microbiome and gastrointestinal physiology in healthy adults: a randomised, controlled cross-over feeding study

2026

Journal Article

Altered Duodenal Mucosa-Associated Microbiota and Immune Profiles in Functional Dyspepsia: A Study of Host-Microbiome Homeostasis

Hoedt, Emily C., Burns, Grace L., Kang, Seungha, Bruce, Jessica, Morrison, Mark, Keely, Simon and Talley, Nicholas J. (2026). Altered Duodenal Mucosa-Associated Microbiota and Immune Profiles in Functional Dyspepsia: A Study of Host-Microbiome Homeostasis. Neurogastroenterology and Motility, 38 (1) e70238, 1. doi: 10.1111/nmo.70238

Altered Duodenal Mucosa-Associated Microbiota and Immune Profiles in Functional Dyspepsia: A Study of Host-Microbiome Homeostasis

2025

Journal Article

The microbiome and gut–lung axis in nontuberculous mycobacterial pulmonary disease

Thompson, Ria N., Blumenthal, Antje, Morrison, Mark and Thomson, Rachel M. (2025). The microbiome and gut–lung axis in nontuberculous mycobacterial pulmonary disease. PLOS Pathogens, 21 (10) e1013603, 1-25. doi: 10.1371/journal.ppat.1013603

The microbiome and gut–lung axis in nontuberculous mycobacterial pulmonary disease

Current funding

  • 2025 - 2026
    Metabolomic signatures of the duodenal mucosa associated microbiota in Primary Sclerosing Cholangitis (PSC) and its associated Inflammatory Bowel Disease (IBD)
    University of Newcastle
    Open grant
  • 2024 - 2029
    Centre of Research Excellence in Transforming Gut Health (a 2024 NHMRC Centres of Research Excellence grant led by The University of Newcastle)
    University of Newcastle
    Open grant
  • 2024 - 2027
    Harnessing microbial immunomodulatory function to improve treatment of inflammatory bowel diseases
    NHMRC IDEAS Grants
    Open grant
  • 2022 - 2026
    Microbiome Manipulation to Treat and Cure Inflammatory Bowel Disease (NHMRC Investigator Grant led by CI Kamm University of Melbourne)
    University of Melbourne
    Open grant
  • 2021 - 2026
    Drugs from Bugs: Developing New Inflammatory Bowel Disease Drugs from Gut Bacteria-Derived Bioactives
    United States Congressionally Directed Medical Research Programs - Peer Reviewed Medical Research Program
    Open grant

Past funding

  • 2024 - 2025
    Onco-Derm: a single site prospective analysis of skin microbiome as a predictor of toxicity in patients receiving immune checkpoint inhibitor therapy
    Microba Pty Ltd
    Open grant
  • 2023 - 2024
    Responses of duodenal spheroid cultures to the secretomes of duodenal microbiota from patients with and without disorders of gut brain interactions (NHMRC CRE led by University of Newcastle)
    University of Newcastle
    Open grant
  • 2023 - 2025
    Investigating gastrointestinal biofilms regarding biochemistry and links with clinical manifestations (2023 MSHRSS Co-funded Collaboration Grant led by MSH)
    Metro South Research Support Scheme Co-funded Collaboration Grant
    Open grant
  • 2022 - 2023
    The effects of variable doses of STW 5 and STW 5-II on bacterial isolates from the duodenum and the duodenal mucosa-associated microbiomes from subjects with and without functional GI symptoms
    Bayer - Steigerwald Arzneimittelwerk GmbH
    Open grant
  • 2022 - 2025
    Defining host immune and microbial determinants of disease trajectory in mycobacterial infection
    Metro South Hospital and Health Service
    Open grant
  • 2022
    Linking the presence of live Ileal-derived bacteria in the joint as a triggering factor for the development of Spondyloarthropathy.
    Arthritis Foundation of Australia
    Open grant
  • 2021 - 2022
    Impacts of food additives on the duodenal mucosa-associated microbiota
    University of Newcastle
    Open grant
  • 2021 - 2025
    Bringing Archaeal biodiversity to life from native Australian herbivores
    ARC Discovery Projects
    Open grant
  • 2020 - 2024
    Modulation of the Gastrointestinal Microbiome with probiotics and subsequent Methane production as a novel approach to treat constipation: A Proof of Principle Study (TRI Sport Grant led by PAH)
    Metro South Hospital and Health Service
    Open grant
  • 2020 - 2021
    Comparative Genomic Sequencing of selected strains of probiotic bacteria - Phase II
    Innovation Connections
    Open grant
  • 2020 - 2021
    Functionally characterizing IBD dysbiosis and harnessing gut bioactives to suppress IL-23 driven inflammation
    The Global Grants for Gut Health
    Open grant
  • 2020 - 2025
    Creating an evidence base for clinical care: A randomized controlled study examining the efficacy of the low FODMAP diet for... (MRFF EPCDR Endometriosis Grant led by Monash)
    Monash University
    Open grant
  • 2020 - 2025
    Targeting the gut microbiome as a treatment for Primary Sclerosing Cholangitis: The Queensland Clinical Network Study
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2019 - 2024
    Centre for Research Excellence in Digestive Health (NHMRC CRE administered by University of Newcastle)
    University of Newcastle
    Open grant
  • 2019 - 2020
    Comparative Genomic Sequencing of selected strains of probiotic bacteria
    Innovation Connections
    Open grant
  • 2017 - 2020
    Invention of a Genetic Toolkit for Immunomodulatory Gut Bacteria to Expedite the Development of New Crohn's Disease Therapeutics
    United States Congressionally Directed Medical Research Programs - Peer Reviewed Medical Research Program
    Open grant
  • 2017 - 2018
    Prebiotic Study of Faecal Samples - Using Diets Rich in Dietary Fibre to Improve Bowel Habit and Sense of Wellbeing
    Monash University
    Open grant
  • 2017 - 2022
    The ENIGMA project: Eastern Inflammatory Bowel Disease Gut Microbiota
    Australasian Gastro Intestinal Research Foundation
    Open grant
  • 2017 - 2020
    Epithelial metabolism as a mediator of host-microbiome interactions in inflammatory bowel disease (NHMRC Project Grant administered by The University of Newcastle)
    University of Newcastle
    Open grant
  • 2017 - 2018
    Linking maternal and infant microbiome: effects of GDM or effects of probiotics?
    Diabetes Australia Research Program
    Open grant
  • 2016 - 2019
    Rapid functional and taxonomic skin microbe characterisation
    ARC Linkage Projects
    Open grant
  • 2016 - 2020
    Design rules for nutritionally-functional grains
    ARC Linkage Projects
    Open grant
  • 2016
    Establishing a gnotobiotic germ-free mouse facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    Instrumentation for the analysis of cellular and metabolic phenotypes
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    Modification of the microbiome to protect against spondyloarthropathy in SKG mice
    Arthritis Foundation of Australia
    Open grant
  • 2016
    The Australian human microbiota project-microbe isolation facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015 - 2017
    Microbiome in highly trained athletes and response to dietary change
    Australian Institute Sport
    Open grant
  • 2015
    Design rules for nutritionally-functional starches
    UQ Collaboration and Industry Engagement Fund - Seed Research Grant
    Open grant
  • 2015 - 2017
    Evolution of the marsupial gut microbiome and adaptation to eucalypt toxins
    ARC Discovery Projects
    Open grant
  • 2015 - 2018
    Pathophysiology of functional dyspepsia: Integration of upper gut function, inflammation and a systems biology approach.
    NHMRC Project Grant
    Open grant
  • 2015 - 2016
    Your microbiome or your mother's? The relationship between the microbiomes of mothers and babies
    Royal Brisbane and Women's Hospital
    Open grant
  • 2014 - 2017
    Interactions between host and the gut microbiome in the pathogenesis of ankylosing spondylitis and Crohn's disease
    NHMRC Project Grant
    Open grant
  • 2014 - 2015
    Bringing genomes to life: isolation of genetically tractable, not-yet-cultured members of the human microbiota using metaparental mating methods
    PA Research Foundation
    Open grant
  • 2014 - 2018
    Determinants of progression of actinic keratoses to squamous cancer
    NHMRC Project Grant
    Open grant

Availability

Professor Mark Morrison is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

Completed supervision

Enquiries

For media enquiries about Professor Mark Morrison's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au